Researchers have developed and validated a multiresidue method for pesticide and veterinary drug detection in animal feeds using liquid- and gas chromatography with tandem mass spectrometry (LC–MS/MS and GC–MS/MS).
Photo Credit: stock.adobe.com/dusanpetkovic1
Contaminated livestock feeds can have severe health implications to the animals themselves and also to the consumers of animals products further down the agricultural production chain. Two major concerns are pesticides and veterinary drugs which find their way into livestock feeds for different reasons. As livestock feeds tend to be the by-products of cereals, pulses and oilseeds they will have previously been treated with pesticides, and despite processing treatments, some can remain in the final food product given to the animals. The consumption of contaminated feeds can cause severe health complications for livestock including lung and liver cancer, mutation in chromosomes, teratogenicity, nephrotoxicity and hepatotoxicity (2,3).
Alternatively, veterinary drugs are often purposely inserted into animal feeds to administer treatments to the animal without the need for injections. While this is an easier process it can lead to higher than necessary dosages being administered and can also lead to complications if administered at the wrong time with residues remaining in the tissues of farm animals and going on to affect humans further down the food chain.
Many reported methods exist which analyse pesticides and veterinary drugs separately in animal feed matrices, whereas only a few studies exist that use a single method for the simultaneous estimation of contaminant residues. Therefore, researchers aimed to develop and validate a single method for the analysis of wide range of pesticides and frequently used veterinary drugs by using both LC–MS/MS and GC–MS/MS.
The developed method, which included a single extraction and optimized sample preparation workflow, successfully detected 192 pesticides during GC–MS/MS analysis and 187 compounds, including 17 veterinary drugs, during LC–MS/MS analysis. The validated methods performance also complied with the requirements of EU-MRLs and DG-SANTE’s analytical quality control criteria, and is therefore suitable for regulatory and commercial testing purposes.
References
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.